Aura Biosciences, Inc. (AURA)
NASDAQ
Market Cap
$353.24M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
32 of 809
Rank in Industry
27 of 445
Largest Insider Buys in Sector
AURA Stock Price History Chart
AURA Stock Performance
About Aura Biosciences, Inc.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Aura Biosciences, Inc.
Over the last 12 months, insiders at Aura Biosciences, Inc. have bought $15.23M and sold $396,895 worth of Aura Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Aura Biosciences, Inc. have bought $21.79M and sold $263,885 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Matrix Capital Management Company, LP (10 percent owner) — $28.08M. Johnson David Michael (director) — $2.39M.
The last purchase of 1,560,000 shares for transaction amount of $14.04M was made by Matrix Capital Management Company, LP (10 percent owner) on 2023‑11‑09.
List of Insider Buy and Sell Transactions, Aura Biosciences, Inc.
| 2024-01-23 | Sale | de los Pinos Elisabet | See Remarks | 15,853 0.0323% | $7.64 | $121,141 | -1.70% | |
| 2024-01-23 | Sale | Feder Julie B | Chief Financial Officer | 6,609 0.0135% | $7.64 | $50,521 | -1.70% | |
| 2023-11-09 | Matrix Capital Management Company, LP | 10 percent owner | 1.56M 5.251% | $9.00 | $14.04M | +11.36% | ||
| 2023-11-08 | Johnson David Michael | director | 19,601 0.0517% | $7.30 | $143,087 | +8.61% | ||
| 2023-11-07 | Johnson David Michael | director | 123,000 0.3185% | $7.17 | $881,910 | +9.70% | ||
| 2023-11-06 | Sale | de los Pinos Elisabet | See Remarks | 7,449 0.0211% | $12.03 | $89,611 | -30.12% | |
| 2023-11-06 | Sale | Feder Julie B | Chief Financial Officer | 3,900 0.0111% | $12.07 | $47,054 | -30.12% | |
| 2023-10-30 | Sale | de los Pinos Elisabet | See Remarks | 9,586 0.0229% | $6.83 | $65,478 | +5.09% | |
| 2023-10-30 | Sale | Feder Julie B | Chief Financial Officer | 3,385 0.0081% | $6.82 | $23,091 | +5.09% | |
| 2023-10-04 | Johnson David Michael | director | 6,566 0.0178% | $8.61 | $56,512 | -8.75% | ||
| 2023-10-03 | Johnson David Michael | director | 13,500 0.0352% | $8.27 | $111,663 | -7.29% | ||
| 2023-01-06 | Johnson David Michael | director | 904 0.0024% | $10.51 | $9,501 | -3.81% | ||
| 2023-01-05 | Johnson David Michael | director | 396 0.001% | $10.00 | $3,960 | -2.60% | ||
| 2022-12-28 | Johnson David Michael | director | 2,000 0.0066% | $9.75 | $19,500 | +3.45% | ||
| 2022-12-05 | Matrix Capital Management Company, LP | director | 1.25M 4.0472% | $12.00 | $15M | -16.68% | ||
| 2022-12-01 | Johnson David Michael | director | 5,000 0.0154% | $12.37 | $61,850 | -23.03% | ||
| 2022-10-31 | Sale | de los Pinos Elisabet | See Remarks | 5,706 0.0192% | $12.46 | $71,082 | -15.25% | |
| 2022-10-31 | Sale | Rich Cadmus | See Remarks | 1,672 0.0056% | $12.45 | $20,813 | -15.25% | |
| 2022-10-31 | Sale | Feder Julie B | Chief Financial Officer | 2,015 0.0068% | $12.45 | $25,090 | -15.25% | |
| 2022-10-31 | Sale | De Rosch Mark | Chief Operating Officer | 1,115 0.0037% | $12.46 | $13,890 | -15.25% |
Insider Historical Profitability
<0.0001%
| Matrix Capital Management Company, LP | 10 percent owner | 6922870 14.0717% | $7.13 | 3 | 0 | <0.0001% |
| de los Pinos Elisabet | See Remarks | 161438 0.3281% | $7.13 | 0 | 4 | |
| Johnson David Michael | director | 135667 0.2758% | $7.13 | 9 | 0 | <0.0001% |
| Feder Julie B | Chief Financial Officer | 62991 0.128% | $7.13 | 0 | 4 | |
| Medicxi Ventures Management (Jersey) Ltd | director | 2969352 6.0356% | $7.13 | 1 | 0 | <0.0001% |
| Rich Cadmus | See Remarks | 24578 0.05% | $7.13 | 0 | 1 | |
| De Rosch Mark | Chief Operating Officer | 16385 0.0333% | $7.13 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Matrix Capital Management Company, L.P. | $54.34M | 13.97 | 6.92M | 0% | +$0 | 0.51 | |
| Eventide Asset Management | $45.55M | 11.71 | 5.8M | 0% | +$0 | 0.72 | |
| Adage Capital Partners Gp L L C | $35.05M | 9.01 | 4.46M | +5.68% | +$1.88M | 0.06 | |
| Citadel Advisors LLC | $28.86M | 7.42 | 3.68M | +1.24% | +$353,077.30 | 0.02 | |
| Medicxi Growth I Lp | $23.86M | 6.14 | 3.04M | 0% | +$0 | 6.26 | |
| BlackRock | $19.19M | 4.93 | 2.44M | +16.49% | +$2.72M | <0.0001 | |
| The Vanguard Group | $13.25M | 3.41 | 1.69M | -2.49% | -$337,714.84 | <0.0001 | |
| Franklin Templeton Investments | $11.41M | 2.93 | 1.45M | +142.18% | +$6.7M | <0.01 | |
| Nantahala Capital Management Llc | $10.38M | 2.67 | 1.32M | 0% | +$0 | 1.06 | |
| Goldman Sachs | $7.82M | 2.01 | 996,643 | -3.92% | -$319,149.62 | <0.01 | |
| Regency Capital Management Inc De | $6.16M | 1.59 | 785,136 | +11.37% | +$629,271.74 | 4.01 | |
| Geode Capital Management | $6.13M | 1.58 | 781,190 | +15.54% | +$824,861.98 | <0.01 | |
| T. Rowe Price | $4.68M | 1.2 | 595,540 | -9.72% | -$503,702.11 | <0.01 | |
| State Street | $4.47M | 1.15 | 569,804 | +12.55% | +$498,804.66 | <0.0001 | |
| Long Focus Capital Management Llc | $3.89M | 1 | 495,422 | +45.53% | +$1.22M | 0.45 | |
| Ensign Peak Advisors Inc | $2.8M | 0.72 | 357,222 | 0% | +$0 | 0.01 | |
| Northern Trust | $2.33M | 0.6 | 296,323 | +19.28% | +$375,952.27 | <0.0001 | |
| Fidelity Investments | $2.31M | 0.6 | 294,654 | -17.47% | -$489,690.87 | <0.0001 | |
| Jefferies Financial Group | $1.75M | 0.45 | 222,497 | New | +$1.75M | 0.03 | |
| Dimensional Fund Advisors | $1.64M | 0.42 | 208,664 | +17.41% | +$242,926.04 | <0.0001 | |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1.41M | 0.36 | 180,145 | 0% | +$0 | 0.02 | |
| Verition Fund Management Llc | $1.19M | 0.31 | 151,681 | -0.33% | -$3,964.25 | 0.01 | |
| Two Sigma | $894,029.00 | 0.23 | 113,889 | +168.69% | +$561,290.92 | <0.01 | |
| Levin Capital Strategies | $872,920.00 | 0.22 | 111,200 | +11.2% | +$87,920.00 | 0.09 | |
| Td Asset Management Inc | $847,109.00 | 0.22 | 107,912 | 0% | +$0 | <0.01 | |
| Charles Schwab | $834,015.00 | 0.21 | 106,244 | +16.18% | +$116,148.54 | <0.0001 | |
| D. E. Shaw & Co. | $749,243.00 | 0.19 | 95,445 | +58.91% | +$277,740.76 | <0.01 | |
| BNY Mellon | $741,651.00 | 0.19 | 94,478 | +4.64% | +$32,914.99 | <0.0001 | |
| Morgan Stanley | $681,821.00 | 0.18 | 86,856 | +4.94% | +$32,098.72 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $562,735.00 | 0.15 | 71,686 | +454.76% | +$461,297.32 | <0.01 | |
| Millennium Management LLC | $555,128.00 | 0.14 | 70,717 | New | +$555,128.00 | <0.0001 | |
| Nuveen | $551,455.00 | 0.14 | 70,249 | 0% | +$0 | <0.0001 | |
| Ubs Oconnor Llc | $528,501.00 | 0.14 | 67,325 | -25.19% | -$177,998.67 | 0.05 | |
| TBH Global Asset Management | $473,530.00 | 0.12 | 60,322 | 0% | +$0 | 0.1 | |
| Renaissance Technologies | $448,000.00 | 0.12 | 57,100 | +100.35% | +$224,392.29 | <0.01 | |
| The Manufacturers Life Insurance Company | $441,625.00 | 0.11 | 56,258 | +0.57% | +$2,512.00 | <0.0001 | |
| New York Life Investment Management Llc | $366,862.00 | 0.09 | 46,734 | New | +$366,862.00 | <0.01 | |
| RhumbLine Advisers | $356,947.00 | 0.09 | 45,472 | +14.01% | +$43,872.64 | <0.0001 | |
| Exchange Traded Concepts, LLC | $299,831.00 | 0.08 | 38,195 | +156.36% | +$182,873.75 | 0.01 | |
| Marshall Wace | $292,083.00 | 0.08 | 37,208 | New | +$292,083.00 | <0.0001 | |
| UBS | $287,671.00 | 0.07 | 36,646 | +17.98% | +$43,834.39 | <0.0001 | |
| Bank of America | $274,224.00 | 0.07 | 34,933 | -1.49% | -$4,136.95 | <0.0001 | |
| Alps Advisors Inc | $272,364.00 | 0.07 | 34,696 | +3.08% | +$8,132.61 | <0.01 | |
| Two Sigma Advisers LP | $247,275.00 | 0.06 | 31,500 | New | +$247,275.00 | <0.0001 | |
| Values First Advisors, Inc. | $214,232.00 | 0.06 | 27,291 | +149.71% | +$128,440.29 | 0.05 | |
| Barclays | $199,000.00 | 0.05 | 25,394 | -33.47% | -$100,111.25 | <0.0001 | |
| JPMorgan Chase | $190,636.00 | 0.05 | 24,285 | +32.27% | +$46,510.94 | <0.0001 | |
| Letko Brosseau | $166,420.00 | 0.04 | 21,200 | New | +$166,420.00 | <0.01 | |
| Jane Street Capital | $165,023.00 | 0.04 | 21,022 | -26.97% | -$60,955.36 | <0.0001 | |
| Susquehanna International Group | $144,393.00 | 0.04 | 18,394 | +69.91% | +$59,408.84 | <0.0001 |